Liofen XL 30 Capsule contains Baclofen 30 mg, a centrally acting skeletal muscle relaxant primarily indicated for the management of spasticity associated with multiple sclerosis, spinal cord injuries, and other neurological disorders. Baclofen exerts its therapeutic effect by activating GABA-B receptors in the central nervous system, resulting in inhibition of excitatory neurotransmitter release and subsequent reduction of muscle spasticity and rigidity. Liofen XL 30 is formulated as an extended-release capsule to provide a sustained therapeutic effect, allowing for once or twice daily dosing, which enhances patient compliance and maintains steady plasma drug concentrations. This medication is particularly useful in alleviating muscle stiffness, spasms, and pain, thereby improving mobility and quality of life in affected patients. It should be used under strict medical supervision, with careful dose titration to minimize adverse effects such as drowsiness, dizziness, weakness, and potential withdrawal symptoms upon abrupt discontinuation. Liofen XL 30 is contraindicated in patients with hypersensitivity to Baclofen and should be used cautiously in those with renal impairment or seizure disorders. Regular monitoring and adherence to prescribed dosage are essential to optimize therapeutic outcomes and minimize risks.